MARKET

FHTX

FHTX

Foghorn Therapeutics Inc.
NASDAQ
4.200
-0.330
-7.28%
After Hours: 4.410 +0.21 +5.00% 17:01 05/09 EDT
OPEN
4.530
PREV CLOSE
4.530
HIGH
4.605
LOW
4.160
VOLUME
97.32K
TURNOVER
--
52 WEEK HIGH
10.25
52 WEEK LOW
2.945
MARKET CAP
234.03M
P/E (TTM)
-2.6619
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FHTX last week (0428-0502)?
Weekly Report · 5d ago
Foghorn Therapeutics Appoints New Board Members
TipRanks · 05/01 20:17
Foghorn Therapeutics appoints Neil Gallagher, Stuart Duty to board
TipRanks · 05/01 11:41
Foghorn Therapeutics Elects Neil Gallagher, M.D., Ph.D., and Stuart Duty to Board of Directors
NASDAQ · 05/01 11:14
FOGHORN THERAPEUTICS APPOINTS NEIL GALLAGHER AND STUART DUTY TO ITS BOARD OF DIRECTORS
Reuters · 05/01 11:00
Press Release: Foghorn Therapeutics Appoints Neil Gallagher and Stuart Duty to its Board of Directors
Dow Jones · 05/01 11:00
Foghorn Therapeutics Price Target Maintained With a $9.00/Share by JMP Securities
Dow Jones · 04/30 15:00
JMP Securities Reiterates Market Outperform on Foghorn Therapeutics, Maintains $9 Price Target
Benzinga · 04/30 14:50
More
About FHTX
More
Foghorn Therapeutics Inc. is a clinical-stage, precision therapeutics biotechnology company. The Company is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control platform, it is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is also developing multiple product candidates in oncology. The Gene Traffic Control platform provides an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within this system. Its platform enables to produce components of the chromatin regulatory system at scale, thereby allowing to identify these genetic dependencies, understand their mechanism and target their vulnerabilities.
Recently
Symbol
Price
%Change

Webull offers Foghorn Therapeutics Inc. stock information, including NASDAQ: FHTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FHTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FHTX stock methods without spending real money on the virtual paper trading platform.